Sales of GlaxoSmithKline's rotavirus vaccine Rotarix and Merck's shingles vaccine Zostavax will be buoyed by their inclusion on the U.K. national immunization schedule.
British health officials selected GlaxoSmithKline's Rotarix vaccine for the country's first routine rotavirus immunization program.
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>
Rwanda's government has launched a national rotavirus vaccination program using Merck's RotaTeq oral rotavirus vaccine. The program will include all infants in the country, meaning that over 100,000 children will get the vaccine before the end of 2012.
The deal cuts the price for the vaccines 67 percent and means vaccines for 70 million children in the world's 40 poorest countries by 2016.
A new oral vaccine from Australia could help to cut deaths from rotavirus infections, in the developing as well as the developed world.
In the past, vaccines against rotavirus, an infection causing severe diarrhea, have been linked with serious bowel problems and blockages in infants, but a large-scale study of over three-quarters of
MSD Wellcome Trust Hilleman Laboratories, set up in India last year with support from Merck, will attempt to make a copy of the company's Rotateq vaccine for the prevention of diarrhea. Researchers
Rotavirus vaccines are in the clear. The FDA has decreed that both GlaxoSmithKline's ( NYSE: GSK ) Rotarix and Merck's ( NYSE: MRK ) Rotateq are safe despite their contamination with DNA from a pig virus